N
Nelson B. Watts
Researcher at University of Cincinnati Academic Health Center
Publications - 215
Citations - 20940
Nelson B. Watts is an academic researcher from University of Cincinnati Academic Health Center. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 59, co-authored 209 publications receiving 18999 citations. Previous affiliations of Nelson B. Watts include Emory University & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Reversible impairment of gonadotropin secretion in critical illness. Observations in postmenopausal women.
Suzanne S. P. Gebhart,Nelson B. Watts,Richard V. Clark,Guillermo E. Umpierrez,Demetrios S. Sgoutas +4 more
TL;DR: Critically ill postmenopausal women may exhibit a marked fall in gonadotropin, LH, and FSH levels, and results from pituitary unresponsiveness to gonadorelin hydrochloride.
Journal ArticleDOI
Management of osteoporosis among home health and long-term care patients with a prior fracture.
Amy H. Warriner,Ryan C. Outman,Kenneth G. Saag,Sarah D. Berry,Cathleen S. Colón-Emeric,Kellie L. Flood,Kenneth W. Lyles,S. Bobo Tanner,Nelson B. Watts,Jeffrey R. Curtis +9 more
TL;DR: An algorithm for the assessment and treatment of osteoporosis among persons with known prior fracture living in long-term care facilities or receiving home health care based on the data available in the literature is developed.
Journal ArticleDOI
Review of treatment modalities for postmenopausal osteoporosis
Ronald C. Hamdy,Charles H. Chesnut,Margery Gass,Michael F. Holick,Edward S. Leib,Michael E. Lewiecki,Michael Maricic,Nelson B. Watts +7 more
TL;DR: This review summarizes and updates data presented at recent annual Southern Medical Association conferences on postmenopausal osteoporosis and indicates drugs on the horizon include strontium ranelate, which has been shown to reduce vertebral and nonvertebral fracture risk, and zoledronic acid, an injectable bisphosphonate that increased bone density with once-yearly administration.
Journal Article
Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
TL;DR: The role of estrogen alone or in combination with androgen as hormone replacement therapy is discussed for its potential value in osteoporosis prevention and treatment.
Journal ArticleDOI
Osteonecrosis of the jaw.
TL;DR: Osteonecrosis of the jaw (ONJ) is a newly described condition (2003) defined as exposed bone in the maxillofacial area, not associated with radiation or any other known cause and not healing for 8 weeks, and it does occur in patients receiving oral or i.v. bisphosphonate therapy for cancer.